MedTrace Logo

DCE-MRI Based on 4D Free Breathing for Predicting Preoperative Neoadjuvant Chemoradiotherapy for Esophageal Cancer

NCT06755866 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2025-01-01

No results posted yet for this study

Summary

To prospectively collect medical images and clinical data related to esophageal cancer using 4D Free Breathing DCE-MRI technology, to evaluate the image quality in the diagnosis of esophageal cancer, and to predict the efficacy of preoperative neoadjuvant chemoradiotherapy for esophageal cancer.

Conditions

  • Esophageal Cancer

Interventions

DIAGNOSTIC_TEST

The application value of MRI 4D Free Breathing DCE-MRI in the treatment of esophageal cancer

Chest MRI scan outside of standard treatment options

Sponsors & Collaborators

  • Yunnan Cancer Hospital

    lead OTHER

Principal Investigators

  • Lianhua Ye · Ethics Committee of Yunnan Provincial Cancer Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-26
Primary Completion
2026-07-31
Completion
2026-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06755866 on ClinicalTrials.gov